1. Home
  2. GSAT vs BLCO Comparison

GSAT vs BLCO Comparison

Compare GSAT & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GSAT
  • BLCO
  • Stock Information
  • Founded
  • GSAT 2003
  • BLCO 1853
  • Country
  • GSAT United States
  • BLCO Canada
  • Employees
  • GSAT N/A
  • BLCO N/A
  • Industry
  • GSAT Telecommunications Equipment
  • BLCO Ophthalmic Goods
  • Sector
  • GSAT Consumer Discretionary
  • BLCO Health Care
  • Exchange
  • GSAT Nasdaq
  • BLCO Nasdaq
  • Market Cap
  • GSAT 5.5B
  • BLCO 5.2B
  • IPO Year
  • GSAT 2006
  • BLCO 2022
  • Fundamental
  • Price
  • GSAT $45.32
  • BLCO $15.67
  • Analyst Decision
  • GSAT Strong Buy
  • BLCO Hold
  • Analyst Count
  • GSAT 4
  • BLCO 12
  • Target Price
  • GSAT $49.00
  • BLCO $15.91
  • AVG Volume (30 Days)
  • GSAT 1.1M
  • BLCO 502.0K
  • Earning Date
  • GSAT 11-06-2025
  • BLCO 10-29-2025
  • Dividend Yield
  • GSAT N/A
  • BLCO N/A
  • EPS Growth
  • GSAT N/A
  • BLCO N/A
  • EPS
  • GSAT N/A
  • BLCO N/A
  • Revenue
  • GSAT $260,664,000.00
  • BLCO $4,891,000,000.00
  • Revenue This Year
  • GSAT $7.93
  • BLCO $8.29
  • Revenue Next Year
  • GSAT $11.32
  • BLCO $5.82
  • P/E Ratio
  • GSAT N/A
  • BLCO N/A
  • Revenue Growth
  • GSAT 14.85
  • BLCO 8.81
  • 52 Week Low
  • GSAT $15.00
  • BLCO $10.45
  • 52 Week High
  • GSAT $47.44
  • BLCO $20.94
  • Technical
  • Relative Strength Index (RSI)
  • GSAT 65.71
  • BLCO 61.17
  • Support Level
  • GSAT $42.84
  • BLCO $14.67
  • Resistance Level
  • GSAT $46.04
  • BLCO $15.90
  • Average True Range (ATR)
  • GSAT 2.47
  • BLCO 0.46
  • MACD
  • GSAT -0.19
  • BLCO 0.08
  • Stochastic Oscillator
  • GSAT 76.02
  • BLCO 89.23

About GSAT Globalstar Inc.

Globalstar Inc is a telecommunications company that derives revenue from the provision of mobile satellite services. Mobile satellite services are typically used by customers where existing terrestrial wireline and wireless communications networks are impaired or do not exist. The company provides communications services such as two-way voice and data transmission. In addition, one-way data transmission is also offered. Both services are offered using mobile or fixed devices. The company is an owner of satellite assets. It has one reportable segment: MSS business. The company generates the vast majority of its revenue within the United States.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: